Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease (IBD) have been dashed. | Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease ...

Conformal Medical has raised $32 million to support the development of its heart implant designed to reduce the lifetime risk ...

Hatteras Venture Partners has secured over $200 million across a pair of funds that are set to benefit up-and-coming biotechs ...

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

Oric Pharmaceuticals’ previously announced plan to focus resources on its two most advanced oncology drugs comes with a sting ...

Generation Bio is shedding 90% of its workforce after the biotech acknowledged that it’s unlikely to find the cash to take ...

The director of the National Institutes of Health (NIH) has said the federal government’s discontinuation of mRNA vaccine ...

More bad news has come down for Biohaven’s small molecule troriluzole. | More bad news has come down for Biohaven’s small molecule troriluzole. After the FDA decided to convene an advisory committee ...

The company said its CGM+ system can deliver accurate readings across a 15-day lifespan, while also employing fewer ...

After the Department of Health and Human Services canceled about $500 million in funding for mR | After HHS abruptly canceled ...

Activist investor Engine Capital is lobbying for big changes at Avantor, urging the life science toolmaker to either cut costs and reshape its management or sell itself outright. | The move comes as ...

Using its hub-and-spoke business model, PureTech is launching a new company to develop deupirfenidone (LYT-100), its ...